# Raytone

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/raytone

- Industry: Pharmaceuticals
- Headquarters: Shenzhen, China
- Latest round: Angel (Jan 18, 2025)
- Investors on record: 4

## About

Established in 2024 and based in Shenzhen, China, Raytone operates as a biopharmaceutical company that mainly provides innovative products for long-acting sustained-release drug delivery to the eye. 

In January 2025, Raytone raised an undisclosed amount of angel funding from new investors Dalton Venture, Triwise Capital, National Innovation Center for High Performance Medical Devices and JenKem Technology Co., Ltd.

Raytone mainly provides ophthalmic disease treatment products. The products launched include disposable eye wash and dry eye treatment products. The disposable eye wash can relieve visual fatigue and vision loss caused by long-term excessive use of the eyes. The dry eye treatment products are for moderate to severe dry eyes. The company generates revenue by providing ophthalmic disease treatment products such as disposable eye wash and dry eye treatment products.

The angel financing will be used by the company to advance clinical trials of the company's core pipeline and accelerate the technical development and pipeline expansion of the iSus® sustained-release platform.

## Funding rounds

- Angel, Jan 18, 2025 — Triwise Capital, Dalton Venture, JenKem Technology Co., Ltd., National Innovation Center for High Performance Medical Devices

## Investors

- Triwise Capital (https://capitalatlas.ai/funds/triwise-capital) — Angel
- Dalton Venture (https://capitalatlas.ai/funds/dalton-venture) — Angel
- JenKem Technology Co., Ltd. — Angel
- National Innovation Center for High Performance Medical Devices — Angel